StockData
Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc. (ORGO) stock

ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/30
$0.80−0.01 (-0.86%)

Close on Nov 16, 2026Market cap $103.34MP/E –Yield –

Organogenesis enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Organogenesis's enterprise value was $89.01M on Nov 11, 2026, against $593.03M a year earlier. Over the last 5 years it ranged from $52.74M to $1.09B, with a median of $328.06M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$89.01M-85.0%
2025Dec 31, 2025$593.03M+80.1%
2024Dec 31, 2024$329.32M-24.9%
2023Dec 29, 2023$438.24M+79.5%
2022Dec 30, 2022$244.14M-77.5%
2021Dec 31, 2021$1.09B+40.6%
2020Dec 31, 2020$772.27M+78.5%
2019Dec 31, 2019$432.55M-32.9%
2018Dec 31, 2018$644.78M+27.5%
2017Dec 29, 2017$505.60M–

More Organogenesis figures

See a number that looks wrong?